BlackSky Technology Inc. Files Amendment to Annual Report

TL;DR

<b>BlackSky Technology Inc. has filed an amendment to its 2023 annual report, providing updated information and disclosures.</b>

AI Summary

BlackSky Technology Inc. (BKSY-WT) filed a Amended Annual Report (10-K/A) with the SEC on April 19, 2024. BlackSky Technology Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2023. The filing was made on April 19, 2024. The company's Class A common stock trades on The New York Stock Exchange under the symbol BKSY. Warrants exercisable for shares of Class A common stock also trade on The New York Stock Exchange under the symbol BKSY.W. The company was formerly known as Osprey Technology Acquisition Corp.

Why It Matters

For investors and stakeholders tracking BlackSky Technology Inc., this filing contains several important signals. This amendment may contain crucial updates or corrections to the original annual filing, impacting investors' understanding of the company's financial health and operational status. Investors and analysts should review the amendment to ensure they are working with the most current and accurate information regarding BlackSky Technology Inc.'s performance and disclosures.

Risk Assessment

Risk Level: low — BlackSky Technology Inc. shows low risk based on this filing. The filing is an amendment to a previous report, indicating potential corrections or additions rather than new material events, thus posing a low immediate risk.

Analyst Insight

Review the specific changes and additions in the 10-K/A filing to understand any updated financial or operational details for BlackSky Technology Inc.

Key Numbers

• 2023-12-31 — Fiscal Year End (Report period)
• 2024-04-19 — Filing Date (Date of amendment filing)
• 001-39113 — SEC File Number (Commission file number)
• 11.50 — Warrant Exercise Price (Price for exercising warrants)

Key Players & Entities

• BlackSky Technology Inc. (company) — Filer name
• BKSY (company) — Trading symbol for Class A common stock
• BKSY.W (company) — Trading symbol for warrants
• The New York Stock Exchange (company) — Exchange where securities are registered
• Osprey Technology Acquisition Corp. (company) — Former company name

FAQ

Industry Context

BlackSky Technology Inc. operates in the technology sector, providing advanced geospatial intelligence solutions.

Regulatory Implications

The company is subject to SEC regulations for public reporting, including annual and amended filings.

What Investors Should Do

1. Review the full 10-K/A filing for detailed amendments and updated financial information.
2. Analyze any changes in risk factors or business descriptions provided in the amendment.
3. Monitor future filings for any further updates or significant developments from BlackSky Technology Inc.

Year-Over-Year Comparison

This is an amendment (10-K/A) to the previously filed annual report for the fiscal year ended December 31, 2023.

Key Financial Figures

• $0.0001 — stered Class A common stock, par value $0.0001 per share BKSY The New York Stock Excha
• $11.50 B — A common stock at an exercise price of $11.50 BKSY.W The New York Stock Exchange Indi
• $30 — any, where he helped grow revenues from $30 to $350 million. Similarly, at DigitalG
• $350 million — ere he helped grow revenues from $30 to $350 million. Similarly, at DigitalGlobe, a vendor o
• $450 million — iness from an early-stage start-up to a $450 million-dollar public market capitalization com

Filing Documents

• bksy-20231231.htm (10-K/A) — 513KB
• 0001753539-24-000054.txt (&nbsp;) — 799KB
• bksy-20231231.xsd (EX-101.SCH) — 2KB
• bksy-20231231_def.xml (EX-101.DEF) — 22KB
• bksy-20231231_lab.xml (EX-101.LAB) — 39KB
• bksy-20231231_pre.xml (EX-101.PRE) — 23KB
• bksy-20231231_htm.xml (XML) — 6KB

Executive Compensation

Executive Compensation 9 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 18 Item 13. Certain Relationships and Related Transactions, and Director Independence 20 Item 14. Principal Accountant Fees and Services 24 Part IV Item 15. Exhibit and Financial Statement Schedules 26 Item 16. Form 10-K Summary 29

Signatures

Signatures 30 2 PART III

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE Our Directors Our business and affairs are managed under the direction of our board of directors (the "Board"). Our Board currently consists of seven directors, five of whom are independent under the listing standards of the New York Stock Exchange, or the NYSE. Our Board is divided into three classes with staggered three-year terms. Only one class of directors is elected at each annual meeting of our stockholders, with the other classes continuing for the remainder of their respective three-year terms. Thus, at each annual meeting of stockholders, a class of directors will be elected for a three-year term to succeed the class whose term is then expiring. The following table sets forth the names, ages as of April 1, 2024 and certain information for each of our directors. There are no arrangements or understandings between any of our directors and any other person pursuant to which he or she is or was to be selected as a director. Name Class Age Position(s) Director of Osprey Technology Acquisition Corp. Director of BlackSky Current Term Expires Magid Abraham (2) (3) I 65 Director - September 2021 - Present 2025 David DiDomenico I 53 Director July 2019 - September 2021 September 2021 - Present 2025 Susan Gordon (3) II 65 Director - September 2021 - Present 2026 Timothy Harvey (1) (2) II 67 Director - September 2021 - Present 2026 Brian O'Toole III 60 Director - September 2021 - Present 2024 William Porteous (1) (2) II 51 Director, Chair - September 2021 - Present 2026 James Tolonen (1) (3) III 74 Director - September 2021 - Present 2024 _____________________ (1) Member of the audit committee (2) Member of the compensation committee (3) Member of the nominating and corporate governance committee Dr. Magid Abraham has served on our Board since September 2021. Dr. Abraham is founder and CEO of Neurawell Therapeutics, a pharmaceutical company developing mental health treatments

View Full Filing

View this 10-K/A filing on SEC EDGAR